Editorial: For $10,000, you get ...
By Sacramento Bee,
Sacramento Bee
| 04. 16. 2006
Frustrated by lawsuits that have held up funding for California's $3 billion stem cell research institute, some of San Francisco's most prominent philanthropists are holding a gala fundraiser for this state agency on May 22.
A press release for "Reach for Tomorrow, Research Today" says the event will offer "private scientific briefings" and "private tours" of nearby campuses for donors willing to contribute up to $10,000 per person, or $100,000 per table. The event also offers a VIP reception, a black-tie dinner and appearances by actress Julie Andrews, composer Marvin Hamlisch and others.
Presumably, the event will also draw university deans and biotech executives who want some exclusive face time with institute leaders - public officials who will be deciding on multi-million-dollar grants to universities and biotech companies. At least three of these public officials are helping to organize the event. These include Institute President Zach Hall, Oversight Committee Chairman Robert Klein II and Vice Chairman Ed Penhoet, listed as honorary co-chairs of "Reach for Tomorrow." (Details can be found at www.reachfortomorrow.info.)
What is wrong with this picture? Plenty, if...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...
